Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

UPDATE 1-Teva Pharmaceutical banks on thrice-weekly Copaxone
Rituximab Use in Pediatric Central Demyelinating Disease.
Immunomodulatory effects of Vitamin D in multiple sclerosis.
4-aminopyridine toxicity: a case report and review of the literature.
Assessment of statistical significance and clinical relevance.
Reduction in healthcare and societal resource utilization associated with cladribine tablets in patients with relapsing-remitting multiple sclerosis: analysis of economic data from the CLARITY Study.
Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE.
The INCAT disability score: A critical analysis of its measurement properties.
The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis.
Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis.
A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder.
Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis.
A controlled trial of mitoxantrone in multiple sclerosis: serial MRI evaluation at one year.
Roche reports positive studies of MabThera given by subcutaneous injection
Takeda Submits a New Drug Application for Glatiramer Acetate in Japan for the Relapse Prevention of Multiple Sclerosis
Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series.
Application of fullerenes in nanomedicine: an update.
Benefit of Endermology on Indurations and Panniculitis/Lipoatrophy During Relapsing-Remitting Multiple Sclerosis Long-Term Treatment with Glatiramer Acetate.
Company restores access to multiple sclerosis drug after pressure from neurologists.
IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis.
Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.
Punctate pattern: A promising imaging marker for the diagnosis of natalizumab-associated PML.
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
Idebenone for primary progressive multiple sclerosis
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Pages